HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoyuki Sakamoto Selected Research

xanthomonasin B

2/2005Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoyuki Sakamoto Research Topics

Disease

19Neoplasms (Cancer)
01/2020 - 01/2005
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2012
3Neoplasm Metastasis (Metastasis)
01/2020 - 11/2005
3Esophageal Neoplasms (Esophageal Cancer)
05/2019 - 08/2016
3Hyperthermia
07/2014 - 05/2007
2Sarcopenia
01/2019 - 08/2016
2Colonic Neoplasms (Colon Cancer)
11/2005 - 02/2005
2Carcinogenesis
10/2005 - 01/2005
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Lymphatic Metastasis
05/2019
1Malnutrition (Nutritional Deficiencies)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Stomatitis
08/2016
1Varicose Veins (Varicose Vein)
04/2009
1Hemorrhage
04/2009
1Adenocarcinoma
02/2005
1Inflammation (Inflammations)
02/2005

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
12/2015 - 07/2011
3NF-kappa B (NF-kB)IBA
05/2007 - 02/2005
2Immunoglobulin G (IgG)IBA
01/2018 - 05/2015
2GemcitabineFDA Link
03/2017 - 01/2012
2Amino AcidsFDA Link
08/2016 - 02/2005
2Interleukin-6 (Interleukin 6)IBA
12/2015 - 02/2012
2Therapeutic UsesIBA
07/2014 - 09/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007 - 02/2005
2Proteins (Proteins, Gene)FDA Link
05/2007 - 02/2005
2Transcription Factors (Transcription Factor)IBA
11/2005 - 02/2005
2monascinIBA
10/2005 - 02/2005
1Pharmaceutical PreparationsIBA
01/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020
1Immune Checkpoint ProteinsIBA
05/2019
1Biomarkers (Surrogate Marker)IBA
05/2019
1squamous cell carcinoma-related antigenIBA
05/2019
1LigandsIBA
05/2019
1AntibodiesIBA
01/2018
1Paclitaxel (Taxol)FDA LinkGeneric
03/2017
1Fluorouracil (Carac)FDA LinkGeneric
03/2017
1Antineoplastic Agents (Antineoplastics)IBA
03/2017
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2015
1activin AIBA
12/2015
1Messenger RNA (mRNA)IBA
12/2015
1AntigensIBA
08/2015
1VimentinIBA
07/2014
1Cadherins (E-Cadherin)IBA
07/2014
1Fibronectins (Fibronectin)IBA
01/2014
1InterferonsIBA
09/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012
1AnticoagulantsIBA
04/2009
1geranylgeranylacetone (teprenone)IBA
05/2007
1NF-KappaB Inhibitor alphaIBA
05/2007
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
05/2007
1E-SelectinIBA
05/2007
1Irinotecan (Camptosar)FDA LinkGeneric
11/2005
1EdaravoneIBA
11/2005
1Peroxynitrous Acid (Peroxynitrite)IBA
10/2005
1Interleukin-10 (Interleukin 10)IBA
02/2005
1Caspase 3 (Caspase-3)IBA
02/2005
1DNA (Deoxyribonucleic Acid)IBA
02/2005
1monascumic acidIBA
02/2005
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2005
1rubropunctatinIBA
02/2005
1rubropunctamineIBA
02/2005
1ankaflavinIBA
02/2005
11,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA
02/2005
1Epstein-Barr virus early antigenIBA
02/2005
1xanthomonasin BIBA
02/2005
1xanthomonasin AIBA
02/2005
1osthenolIBA
01/2005

Therapy/Procedure

8Therapeutics
01/2018 - 07/2011
4Immunotherapy
03/2017 - 07/2011
3Drug Therapy (Chemotherapy)
05/2019 - 03/2017
1Adjuvant Chemotherapy
01/2019
1Chemoradiotherapy
08/2016
1Oral Administration
10/2005